Tag:
Genomind
Latest Headlines
Latest Headlines
Genomind begins depression biomarker study
An inpatient study at the Massachusetts General Hospital (MGH) Department of Psychiatry has started that could validate (or not) the use of a proprietary biomarker panel in treatment-resistant depression.
